Terms: = Bone cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
356 results:
1. Circ_0002669 promotes osteosarcoma tumorigenesis through directly binding to MYCBP and sponging miR-889-3p.
Zhang Y; Zhan Y; Liu Z; Guo H; Liu D; Chen C
Biol Direct; 2024 Apr; 19(1):25. PubMed ID: 38570856
[TBL] [Abstract] [Full Text] [Related]
2. miR-889-3p targeting BMPR2 promotes the development of retinoblastoma via JNK/MAPK/ERK signaling.
Gao Y; Du P
Sci Rep; 2024 Mar; 14(1):7277. PubMed ID: 38538669
[TBL] [Abstract] [Full Text] [Related]
3. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
[TBL] [Abstract] [Full Text] [Related]
4. Esketamine inhibits the c-jun N-terminal kinase pathway in the spinal dorsal horn to relieve bone cancer pain in rats.
Duan C; Zhu Y; Zhang Z; Wu T; Shen M; Xu J; Gao W; Pan J; Wei L; Su H; Shi C
Mol Pain; 2024; 20():17448069241239231. PubMed ID: 38417838
[TBL] [Abstract] [Full Text] [Related]
5. Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma.
Wei L; Meng J; Xiang D; Yang Q; Zhou Y; Xu L; Wang M; Chen J; Han Y
BMC Complement Med Ther; 2024 Jan; 24(1):67. PubMed ID: 38297292
[TBL] [Abstract] [Full Text] [Related]
6. RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma.
Cui X; Huo D; Wang Q; Wang Y; Liu X; Zhao K; You Y; Zhang J; Kang C
Cell Death Dis; 2024 Jan; 15(1):98. PubMed ID: 38286983
[TBL] [Abstract] [Full Text] [Related]
7. Role of Fra-2 in cancer.
Rampioni Vinciguerra GL; Capece M; Scafetta G; Rentsch S; Vecchione A; Lovat F; Croce CM
Cell Death Differ; 2024 Feb; 31(2):136-149. PubMed ID: 38104183
[TBL] [Abstract] [Full Text] [Related]
8. Identification of key genes and their correlation with immune infiltration in osteoarthritis using integrative bioinformatics approaches and machine-learning strategies.
Xia D; Wang J; Yang S; Jiang C; Yao J
Medicine (Baltimore); 2023 Nov; 102(46):e35355. PubMed ID: 37986345
[TBL] [Abstract] [Full Text] [Related]
9. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
10. Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis.
Taylor MR; Cole SW; Strom J; Brazauskas R; Baker KS; Phelan R; Buchbinder D; Hamilton B; Schoemans H; Shaw BE; Sharma A; Bhatt NS; Badawy SM; Winestone LE; Preussler JM; Mayo S; Jamani K; Nishihori T; Lee MA; Knight JM
Blood Adv; 2023 Nov; 7(22):6830-6838. PubMed ID: 37773924
[TBL] [Abstract] [Full Text] [Related]
11. bone marrow fibrosis is associated with non-response to CD19 CAR T-cell therapy in B-acute lymphoblastic leukemia.
Anil J; Alnemri A; Lytle A; Lockhart B; Anil AE; Baumgartner M; Gebre K; McFerran J; Grupp SA; Rheingold SR; Pillai V
Am J Hematol; 2023 Dec; 98(12):1888-1897. PubMed ID: 37718626
[TBL] [Abstract] [Full Text] [Related]
12. CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis.
Behrouzi R; Armstrong AC; Howell SJ
Breast Cancer Res Treat; 2023 Nov; 202(1):83-95. PubMed ID: 37584881
[TBL] [Abstract] [Full Text] [Related]
13. Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis.
Bhasin SS; Thomas BE; Summers RJ; Sarkar D; Mumme H; Pilcher W; Emam M; Raikar SS; Park SI; Castellino SM; Graham DK; Bhasin MK; DeRyckere D
Sci Rep; 2023 Aug; 13(1):12556. PubMed ID: 37532715
[TBL] [Abstract] [Full Text] [Related]
14. Targeting c-jun Is a Potential Therapy for Luminal Breast cancer bone Metastasis.
Han Y; Katayama S; Futakuchi M; Nakamichi K; Wakabayashi Y; Sakamoto M; Nakayama J; Semba K
Mol Cancer Res; 2023 Sep; 21(9):908-921. PubMed ID: 37310848
[TBL] [Abstract] [Full Text] [Related]
15. Butein, a potential drug for the treatment of bone cancer pain through bioinformatic and network pharmacology.
Liu X; Zhao S; Zhao Q; Chen Y; Jia S; Xiang R; Zhang J; Sun J; Xu Y; Zhao M
Toxicol Appl Pharmacol; 2023 Aug; 472():116570. PubMed ID: 37268026
[TBL] [Abstract] [Full Text] [Related]
16. The Role of Fascin-1 in Human Urologic cancers: A Promising Biomarker or Therapeutic Target?
Zhang N; Bian Q; Gao Y; Wang Q; Shi Y; Li X; Ma X; Chen H; Zhao Z; Yu H
Technol Cancer Res Treat; 2023; 22():15330338231175733. PubMed ID: 37246525
[TBL] [Abstract] [Full Text] [Related]
17. Apoptotic effect and cell arrest of deoxyshikonin in human osteosarcoma cells through the p38 pathway.
Hsieh MC; Hsieh YH; Chou CH; Yang JS; Lu PW; Huang TY; Yang SF; Lu KH
J Cell Mol Med; 2023 Jun; 27(11):1592-1602. PubMed ID: 37155410
[TBL] [Abstract] [Full Text] [Related]
18. Genomic Profiling of the Craniofacial Ossifying Fibroma by Next-Generation Sequencing.
Bahceci DH; Grenert JP; Jordan RCK; Horvai AE
Head Neck Pathol; 2023 Sep; 17(3):722-730. PubMed ID: 36928741
[TBL] [Abstract] [Full Text] [Related]
19. Melatonin Inhibits VEGF-Induced Endothelial Progenitor Cell Angiogenesis in Neovascular Age-Related Macular Degeneration.
Lin LW; Wang SW; Huang WC; Huynh TK; Lai CY; Ko CY; Fong YC; Lee JJ; Yang SF; Tang CH
Cells; 2023 Mar; 12(5):. PubMed ID: 36899935
[TBL] [Abstract] [Full Text] [Related]
20. Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing.
Kamolphiwong R; Kanokwiroon K; Wongrin W; Chaiyawat P; Klangjorhor J; Settakorn J; Teeyakasem P; Sangphukieo A; Pruksakorn D
Gene; 2023 Mar; 856():147106. PubMed ID: 36513192
[TBL] [Abstract] [Full Text] [Related]
[Next]
